TOP - Daily

Synribo (omacetaxine mepesuccinate) was recently approved by the FDA to treat adults with chronic myelogenous leukemia (CML) whose cancer has progressed after treatment with at least 2 tyrosine kinase inhibitors (TKIs). Read More ›

Predicting a woman’s long-term risk for developing postmenopausal breast cancer was accomplished through the use of blood hormone testing. Read More ›

For elderly female cancer survivors, achieving and maintaining a healthy body weight, staying physically active, and maintaining a healthy diet can improve survival after a cancer diagnosis. Read More ›

Consuming green tea prior to undergoing prostatectomy reduced markers of inflammation in men with prostate cancer. Read More ›

Individuals with lymphedema must learn how to cope with symptoms throughout their lifetimes. Read More ›

Vegetables, including broccoli and brussel sprouts, were used to create a new compound that has been found to combat triple-negative breast cancer. Read More ›

Annually, Medicare beneficiaries are overpaying by hundreds of dollars for their prescription benefits, an investigation by researchers reveals. Read More ›

The US Administration on Aging forecasts that nearly 1 in 5 Americans will be 65 or older by 2030. Now, a new publication is intended to assist healthcare providers as they interact with this fastest growing sector of America’s population. Read More ›

Recent study findings may clarify the reasons why exercise can significantly reduce the likelihood of secondary cancers in survivors. Read More ›

A recent study shows that with the assistance of patient navigation services, breast cancer patients can reduce delays in the identification of the disease. Read More ›